Drug
VX 548
VX 548: highest development phase Phase 2, developed by Vertex Pharmaceuticals. 2 trial records tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Vertex Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| VX-548 NCT06176196 | Phase 2 | Painful Lumbosacral Radiculopathy |
| VX-548 NCT05541471 | Phase 1 | Pain |
Latest
No recent events.
Follow VX 548 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.